Topic: Oral and Gastrointestinal
Conditions
Interventions
Complications, Immediate complications, if any, will be recorded after the procedure. Patients will be contacted 30 days after the procedure to record any late complication.
Tissue Sampling, On the day of the procedure the patient will be consented for the procedure and for the study and will be randomised to either to obtain biopsy using 22G/25G FNAC needle citology or t
Sponsors
University of Nottingham (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adult patients 18 years and above with a solid pancreatic mass of any size, needing to undergo EUS examination to collect sample for diagnosis. Definition of a solid pancreatic mass will be based on an ultrasound, CT scan or on the findings of a prior EUS. 2. Patients should have the ability and be willing to give informed consent.
Exclusion criteria
Exclusion criteria: 1. Cystic lesions of the pancreas. 2. Patients known to be intolerant to endoscopy. 3. Patients not clinically fit for endoscopy as judged by their cariong team. 4. Patients on anticoagulation therapy. 5. Patients already participating in another trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic accuracy of the standard FNAC needle compared with the new FNAB needle | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Adequacy of the sample obtained with the FNAC needle compared with the new FNAB needle 2. Cost analysis using the FNAC needle compared with the FNAB needle 3. Number of passes needed in obtaining adequate sample using FNAC needle compared with the FNAB needle 4. Time taken in obtaining adequate sample using the FNAC needle compared with the FNAB needle | — |
Countries
United Kingdom
Outcome results
None listed